2011Journal of Cardiovascular and Pulmonary DiseasesRequires access

Effects of large dosage atorvastatin on serum metalloproteinases in patients with acute coronary syndrom

Yiya Zhang

Open publisher page 0 citations

Abstract

Objective:To evaluated the effect of different dosage atorvastatin on serom metalloproteinases(MMP),C-reactive protein(CRP) and lipids in patiente with acute coronary syndrom(ACS) as well as its safty.Methods:46 patients with ACS were randomized to receive atorvastatin(20 mg/d,goup 1) or(40-60 mg/d,group 2) after admition.Serom lipids,CRP and MMP were assessed at baseline,1week and 4 weeks after treatment.Results:1.Compared to baseline,the levels of total cholesterol(TC),LDL-C were significantly reduced after 1 week(P0.05) and 4 weeks(P0.01) in group 2.2.MMP-2,MMP-9 and CRP significantly decreased at 1 week(P0.05)and 4 weeks(P0.01) compared to baseline in two group,But compared to that of group 1,there is more obviously decrease in group 2.3.AST,renal function and creatine kinase remained unchanged after therapy.Conclusion:Large dosage atorvastatin(40-60mg) therapy early is superior to atorvastatin(20mg) in decreasd serom lipids,anti-inflammation and stablised lipide lesion.

About this research paper

What this paper is about

Objective:To evaluated the effect of different dosage atorvastatin on serom metalloproteinases(MMP),C-reactive protein(CRP) and lipids in patiente with acute coronary syndrom(ACS) as well as its safty.Methods:46 patients with ACS were randomized to receive atorvastatin(20 mg/d,goup 1) or(40-60 mg/d,group 2) after admition.Serom lipids,CRP and MMP were assessed at baseline,1week and 4 weeks after treatment.Results:1.Compared to baseline,the levels of total cholesterol(TC),LDL-C were significantly reduced after 1 week(P0.05) and 4 weeks(P0.01) in group 2.2.MMP-2,MMP-9 and CRP significantly decreased at 1 week(P0.05)and 4 weeks(P0.01) compared to baseline in two group,But compared to that of group 1,there is more obviously decrease in group 2.3.AST,renal function and creatine kinase remained unchanged after therapy.Conclusion:Large dosage atorvastatin(40-60mg) therapy early is superior to atorvastatin(20mg) in decreasd serom lipids,anti-inflammation and stablised lipide lesion.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluated the effect of different dosage atorvastatin on serom metalloproteinases(MMP),C-reactive protein(CRP) and lipids in patiente with acute coronary syndrom(ACS) as well as its safty.Methods:46 patients with ACS were randomized to receive atorvastatin(20 mg/d,goup 1) or(40-60 mg/d,group 2) after admition.Serom lipids,CRP and MMP were assessed at baseline,1week and 4 weeks after treatment.Results:1.Compared to baseline,the levels of total cholesterol(TC),LDL-C were significantly reduced after 1 week(P0.05) and 4 weeks(P0.01) in group 2.2.MMP-2,MMP-9 and CRP significantly decreased at 1 week(P0.05)and 4 weeks(P0.01) compared to baseline in two group,But compared to that of group 1,there is more obviously decrease in group 2.3.AST,renal function and creatine kinase remained unchanged after therapy.Conclusion:Large dosage atorvastatin(40-60mg) therapy early is superior to atorvastatin(20mg) in decreasd serom lipids,anti-inflammation and stablised lipide lesion.

Key concepts: Atorvastatin, Medicine, Creatine, Internal medicine, C-reactive protein, Creatine kinase, Matrix metalloproteinase, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of large dosage atorvastatin on serum metalloproteinases in patients with acute coronary syndrom — Research Paper | ScholarLens